| (Values in U.S. Thousands) | Nov, 2024 | Aug, 2024 | May, 2024 | Feb, 2024 | Nov, 2023 |
| Sales | 105,060 | 106,360 | 110,470 | 124,830 | 99,370 |
| Sales Growth | -1.22% | -3.72% | -11.50% | +25.62% | +2.59% |
| Net Income | -121,260 | -23,930 | -27,590 | -7,510 | -21,060 |
| Net Income Growth | -406.73% | +13.27% | -267.38% | +64.34% | +35.85% |
Accolade Inc (ACCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Accolade Inc. provides personalized, technology-enabled solutions which help people better understand, navigate and utilize the healthcare system. Accolade Inc. is based in SEATTLE.
Fiscal Year End Date: 02/29